Skip to main content
Top
Published in: AIDS and Behavior 12/2016

01-12-2016 | Original Paper

Actor–Partner Effects of Male Couples Substance Use with Sex and Engagement in Condomless Anal Sex

Authors: Jason W. Mitchell, Yue Pan, Daniel Feaster

Published in: AIDS and Behavior | Issue 12/2016

Login to get access

Abstract

Few studies have examined actor–partner effects about male couples’ substance use with sex. Dyadic data from 361 male couples were used to examine these effects regarding engagement in condomless anal sex (CAS) by type of partner and substance. Couples with one or both partners reported using marijuana, amyl nitrates, party drugs, and/or stimulants with sex in their relationship was positively associated with them having had CAS. Actor–partner effects for stimulant use with sex with the main partner were associated with CAS with a casual MSM partner. Only an actor effect for stimulant use with sex with a casual MSM partner was associated with CAS with that partner type, and an actor effect for marijuana use with sex for both partner types was associated with CAS with both partner types. These findings illuminate the need for further inquiry about male couples’ substance use with sex for HIV prevention.
Literature
1.
go back to reference Drumright LN, Patterson TL, Strathdee SA. Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse. 2006;41(10–12):1551–601.CrossRefPubMed Drumright LN, Patterson TL, Strathdee SA. Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse. 2006;41(10–12):1551–601.CrossRefPubMed
2.
go back to reference Vosburgh HW, Mansergh G, Sullivan PS, et al. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav. 2012;16(6):1394–410.CrossRefPubMed Vosburgh HW, Mansergh G, Sullivan PS, et al. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav. 2012;16(6):1394–410.CrossRefPubMed
3.
go back to reference Ostrow DG, Plankey MW, Cox C, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr. 2009;51(3):349–55.CrossRefPubMedPubMedCentral Ostrow DG, Plankey MW, Cox C, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr. 2009;51(3):349–55.CrossRefPubMedPubMedCentral
4.
go back to reference Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian epidemics in men who have sex with men (MSM)? PLoS One. 2012;7(11):e50522.CrossRefPubMedPubMedCentral Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian epidemics in men who have sex with men (MSM)? PLoS One. 2012;7(11):e50522.CrossRefPubMedPubMedCentral
6.
go back to reference Mitchell JW, Boyd C, McCabe S, et al. A cause for concern: male couples’ sexual agreements and their use of substances with sex. AIDS Behav. 2014;18(7):1401–11.CrossRefPubMedPubMedCentral Mitchell JW, Boyd C, McCabe S, et al. A cause for concern: male couples’ sexual agreements and their use of substances with sex. AIDS Behav. 2014;18(7):1401–11.CrossRefPubMedPubMedCentral
7.
go back to reference Gamarel KE, Woolf-King SE, Carrico AW, Neilands TB, Johnson MO. Stimulant use patterns and HIV transmission risk among HIV-serodiscordant male couples. J Acquir Immune Defic Syndr. 2015;68(2):147–51.CrossRefPubMedPubMedCentral Gamarel KE, Woolf-King SE, Carrico AW, Neilands TB, Johnson MO. Stimulant use patterns and HIV transmission risk among HIV-serodiscordant male couples. J Acquir Immune Defic Syndr. 2015;68(2):147–51.CrossRefPubMedPubMedCentral
8.
go back to reference Parson JT, Starks TJ. Drug use and sexual arrangements among gay couples: frequency, interependence, and associations with sexual risk. Arch Sex Behav. 2014;43(1):89–98.CrossRef Parson JT, Starks TJ. Drug use and sexual arrangements among gay couples: frequency, interependence, and associations with sexual risk. Arch Sex Behav. 2014;43(1):89–98.CrossRef
9.
go back to reference Kelley HH, Thibaut JW. Interpersonal relations: a theory of interdependence. New York: Wiley; 1978. Kelley HH, Thibaut JW. Interpersonal relations: a theory of interdependence. New York: Wiley; 1978.
10.
go back to reference Kenny D, Kashy D, Cook W. Dyadic data analysis. New York: Guilford Press; 2006. Kenny D, Kashy D, Cook W. Dyadic data analysis. New York: Guilford Press; 2006.
11.
go back to reference Loeys T, Cook W, De Smet O, Wietzker A, Buysse A. The actor–partner interdependence model for categorical dyadic data: a user friendly guide to GEE. Pers Relat. 2014;21(2):225–41.CrossRef Loeys T, Cook W, De Smet O, Wietzker A, Buysse A. The actor–partner interdependence model for categorical dyadic data: a user friendly guide to GEE. Pers Relat. 2014;21(2):225–41.CrossRef
12.
go back to reference Loeys T, Molenberghs G. Modeling actor and partner effects in dyadic data when outcomes are categorical. Psychol Methods. 2013;18(2):220.CrossRefPubMed Loeys T, Molenberghs G. Modeling actor and partner effects in dyadic data when outcomes are categorical. Psychol Methods. 2013;18(2):220.CrossRefPubMed
13.
go back to reference Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefPubMed Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefPubMed
Metadata
Title
Actor–Partner Effects of Male Couples Substance Use with Sex and Engagement in Condomless Anal Sex
Authors
Jason W. Mitchell
Yue Pan
Daniel Feaster
Publication date
01-12-2016
Publisher
Springer US
Published in
AIDS and Behavior / Issue 12/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1355-4

Other articles of this Issue 12/2016

AIDS and Behavior 12/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.